3H](-)nicotine binding sites in fetal human brain

Brain Research
N J Cairns, S Wonnacott

Abstract

The development of putative nicotinic binding sites in brains from human fetuses of 12-19 weeks gestation was studied. The binding of [3H](-)nicotine to fetal human brain membranes, using a rapid filtration method, was saturable and stereospecific. Scatchard analysis revealed a single class of high affinity sites with a Kd of 1.5 +/- 0.5 nM and a Bmax of 4.5 +/- 1.9 fmol/mg protein (n = 11). [3H](-)nicotine binding increased between the ages of 12 and 19 weeks in human fetal brain (r = 0.63, n = 20, P less than 0.01). In competition studies nicotinic agonists were the most effective in inhibiting [3H](-)nicotine binding whereas antagonists were relatively ineffective. Ki values for displacing ligands in the presence of [3H](-)nicotine were: cytisine, 1.6 nM; (-)nicotine, 16 nM; (+) nicotine, 510 nM; dihydro-beta-erythroidine, 1.9 microM; dimethyl-4-phenylpiperazinium, 6.5 microM; choline chloride, 25 microM. Atropine and alpha-bungarotoxin failed to inhibit binding up to 50 microM. Comparison of dissected brain regions revealed regional variations in the density of nicotinic binding sites: specific binding of [3H](-)nicotine was greatest in the nucleus basalis of Meynert, globus pallidus, caudate-putamen and thalamus, and lowes...Continue Reading

References

Jun 11, 1986·Brain Research·S YamadaT Kosuge
Sep 1, 1987·Human Toxicology·S Wonnacott
Sep 1, 1987·Journal of Neurochemistry·E P FiedlerA C Collins
Apr 16, 1986·Brain Research·P J WhitehouseK J Kellar
Oct 1, 1986·Journal of Neurochemistry·E K PerryR H Perry
Dec 1, 1986·Journal of Neurochemistry·S Wonnacott
Nov 1, 1986·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·E K PerryA Fairbairn
Jan 1, 1986·Journal of Neurochemistry·S ShimohamaM Kameyama
Jun 1, 1985·Neuroscience Research·H SugiyamaJ W Lee
Dec 10, 1984·Brain Research·P B ClarkeA Pert
Jan 1, 1984·Journal of Neuroscience Research·H SershenA Lajtha
Nov 1, 1984·Clinical and Experimental Pharmacology & Physiology·L G Costa, S D Murphy
May 1, 1984·Journal of Neurochemistry·E HayashiS Yamada
Nov 7, 1980·Science·C Romano, A Goldstein
Jan 1, 1985·Neurochemistry International·C RapierS Wonnacott
Jan 1, 1985·Neurochemistry International·J WhyteS Wonnacott
Jan 1, 1985·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·N Hagino, J W Lee

❮ Previous
Next ❯

Citations

Apr 24, 1997·Nature·W C DrevetsM E Raichle
Feb 1, 1991·Journal of Periodontology·P J HanesS Lubas
Jan 1, 1990·Molecular Neurobiology·E L OchoaM G McNamee
Jun 1, 1994·Cellular and Molecular Neurobiology·E L Ochoa
Sep 4, 2001·Journal of Developmental and Behavioral Pediatrics : JDBP·M D CorneliusJ A Willford
May 7, 1999·Environmental Health Perspectives·T A Slotkin
Dec 1, 2009·Journal of Neural Transmission·Haukur PálmasonChristine M Freitag
Mar 4, 2003·Journal of Neurophysiology·Vladimir V UteshevRoger L Papke
Jan 1, 2004·Toxicology Mechanisms and Methods·Ramesh C Gupta
Nov 14, 2015·Experimental Brain Research·Alain RíosEnrique Querejeta
Mar 25, 2020·Pharmacological Reviews·M J MoerkeJ L Wilkerson
Aug 7, 1998·Brain Research. Developmental Brain Research·E Hellström-LindahlA Nordberg
Jan 1, 1997·Brain Research Bulletin·C G CampbellT A Slotkin
Nov 19, 1997·Progress in Neurobiology·C GottiF Clementi
Jan 15, 2005·Progress in Neurobiology·C Gotti, F Clementi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.